BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020 AND Treatment
5 results:

  • 1. Racial Disparities in liver Transplantation for Hepatocellular Carcinoma in the United States: An Update.
    Kilani Y; Kamal SAF; Vikash F; Vikash S; Aldiabat M; Alsakarneh S; Aljabiri Y; Sohail H; Kumar V; Numan L; Al Khalloufi K
    Dig Dis Sci; 2023 Oct; 68(10):4050-4059. PubMed ID: 37584869
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor.
    Ho MF; Lai VC; Ng DCK; Ng SSM
    Asian J Surg; 2023 Sep; 46(9):3710-3715. PubMed ID: 36522225
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].
    Gao X; Li Z; Shao XY; Liu XM; Liu C; Liu YP; Qu XJ; Zhang LY
    Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):569-573. PubMed ID: 34034477
    [No Abstract]    [Full Text] [Related]  

  • 4. Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.
    Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Nov; 18(11):1009-15. PubMed ID: 18854779
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Dosimetry of 131I-labeled antiferritin in hepatoma: specific activities in the tumor and liver.
    Leichner PK; Klein JL; Siegelman SS; Ettinger DS; Order SE
    Cancer Treat Rep; 1983; 67(7-8):647-58. PubMed ID: 6307515
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.